Found: 205
Select item for more details and to access through your institution.
Split keyword fuzzy and synonym search over encrypted cloud data.
- Published in:
- Multimedia Tools & Applications, 2018, v. 77, n. 8, p. 10135, doi. 10.1007/s11042-017-5055-5
- By:
- Publication type:
- Article
Clustering with a high-performance secure routing protocol for mobile ad hoc networks.
- Published in:
- Journal of Supercomputing, 2022, v. 78, n. 6, p. 8830, doi. 10.1007/s11227-021-04258-6
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1142, doi. 10.1002/ajh.27271
- By:
- Publication type:
- Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 284, doi. 10.1002/ajh.27156
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. E357, doi. 10.1002/ajh.27086
- By:
- Publication type:
- Article
Germline DDX41 mutant predisposition syndromes: Slow driver states to hematological malignancies.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1673, doi. 10.1002/ajh.27091
- By:
- Publication type:
- Article
Luspatercept use for lower risk myelodysplastic syndromes: Active but not enough.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1171, doi. 10.1002/ajh.27003
- By:
- Publication type:
- Article
Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. 951, doi. 10.1002/ajh.26915
- By:
- Publication type:
- Article
Spectrum of renal pathological findings in patients with chronic myelomonocytic leukemia and kidney injury.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 6, p. E148, doi. 10.1002/ajh.26902
- By:
- Publication type:
- Article
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 681, doi. 10.1002/ajh.26828
- By:
- Publication type:
- Article
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
- By:
- Publication type:
- Article
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
- By:
- Publication type:
- Article
Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 352, doi. 10.1002/ajh.26455
- By:
- Publication type:
- Article
Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS‐RS) but not in MDS/MPN‐RS‐T.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E109, doi. 10.1002/ajh.26448
- By:
- Publication type:
- Article
Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 293, doi. 10.1002/ajh.26441
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E62, doi. 10.1002/ajh.26417
- By:
- Publication type:
- Article
Targeting ineffective hematopoiesis in myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 171, doi. 10.1002/ajh.26416
- By:
- Publication type:
- Article
High‐oxygen‐affinity hemoglobinopathy‐associated erythrocytosis: Clinical outcomes and impact of therapy in 41 cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1647, doi. 10.1002/ajh.26375
- By:
- Publication type:
- Article
Isolated T‐cell acute lymphoblastic leukemic optic disc infiltration.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1717, doi. 10.1002/ajh.26357
- By:
- Publication type:
- Article
Outcomes of venetoclax‐based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E433, doi. 10.1002/ajh.26334
- By:
- Publication type:
- Article
Remarkable stability in clonal hematopoiesis involving leukemia‐driver genes in patients without underlying myeloid neoplasms.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. E392, doi. 10.1002/ajh.26297
- By:
- Publication type:
- Article
Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E327, doi. 10.1002/ajh.26250
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
- By:
- Publication type:
- Article
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
- By:
- Publication type:
- Article
Myelodysplastic syndromes with ring sideroblasts (MDS‐RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN‐RS‐T) – "2021 update on diagnosis, risk‐stratification, and management".
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 379, doi. 10.1002/ajh.26090
- By:
- Publication type:
- Article
Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. E203, doi. 10.1002/ajh.25853
- By:
- Publication type:
- Article
Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. E114, doi. 10.1002/ajh.25748
- By:
- Publication type:
- Article
Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. E86, doi. 10.1002/ajh.25721
- By:
- Publication type:
- Article
Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. E31, doi. 10.1002/ajh.25675
- By:
- Publication type:
- Article
Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 97, doi. 10.1002/ajh.25684
- By:
- Publication type:
- Article
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E231, doi. 10.1002/ajh.25552
- By:
- Publication type:
- Article
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 767, doi. 10.1002/ajh.25488
- By:
- Publication type:
- Article
Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk‐stratification, and Management".
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. 475, doi. 10.1002/ajh.25397
- By:
- Publication type:
- Article
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 5, doi. 10.1002/ajh.25294
- By:
- Publication type:
- Article
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. E401, doi. 10.1002/ajh.25290
- By:
- Publication type:
- Article
Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory‐specific incidence and prognostic impact among 348 informative cases.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1461, doi. 10.1002/ajh.25265
- By:
- Publication type:
- Article
Practice‐relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. E383, doi. 10.1002/ajh.25269
- By:
- Publication type:
- Article
Mutations and karyotype predict treatment response in myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1420, doi. 10.1002/ajh.25267
- By:
- Publication type:
- Article
Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty‐nine patients.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1347, doi. 10.1002/ajh.25246
- By:
- Publication type:
- Article
Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. 1029, doi. 10.1002/ajh.25150
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 824, doi. 10.1002/ajh.25104
- By:
- Publication type:
- Article
U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. E146, doi. 10.1002/ajh.25084
- By:
- Publication type:
- Article
Mutations and prognosis in myelodysplastic syndromes: karyotype‐adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 691, doi. 10.1002/ajh.25064
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 649, doi. 10.1002/ajh.25053
- By:
- Publication type:
- Article
A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. E103, doi. 10.1002/ajh.25037
- By:
- Publication type:
- Article
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 65, doi. 10.1002/ajh.24939
- By:
- Publication type:
- Article